Description
Reta GLP-1 Triple Agonist is an investigational compound developed by Eli Lilly. Also known as a triple agonist, it has activity at GLP-1, GIP, and glucagon receptors.
$139.99
Reta GLP-1 Triple Agonist is supplied as a lyophilized powder.
Reta GLP-1 Triple Agonist is an investigational compound developed by Eli Lilly. Also known as a triple agonist, it has activity at GLP-1, GIP, and glucagon receptors.
| Concentration | 5MG, 10MG |
|---|